These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 8098200)
1. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer]. Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200 [TBL] [Abstract][Full Text] [Related]
2. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations. Gaffey MJ; Frierson HF; Williams ME Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628 [TBL] [Abstract][Full Text] [Related]
3. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Bourhis J; De Vathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; McNally NJ; Lemerle J; Riou G; Bénard J Cancer Res; 1991 Jan; 51(1):33-6. PubMed ID: 1988094 [TBL] [Abstract][Full Text] [Related]
4. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. Tsuda H; Hirohashi S; Shimosato Y; Hirota T; Tsugane S; Yamamoto H; Miyajima N; Toyoshima K; Yamamoto T; Yokota J Cancer Res; 1989 Jun; 49(11):3104-8. PubMed ID: 2566377 [TBL] [Abstract][Full Text] [Related]
5. [DNA content analysis and detection of c-myc and p53 products using flow cytometry in resected lung cancer cases]. Chiba W; Sawai S; Ikeda S; Morimoto K; Wazawa H; Hanawa T; Yamashita N; Matsui T; Hatakenaka R; Matsubara Y Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():108-16. PubMed ID: 8203922 [TBL] [Abstract][Full Text] [Related]
6. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas. Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420 [TBL] [Abstract][Full Text] [Related]
7. Amplification of protooncogenes in surgical specimens of human lung carcinomas. Shiraishi M; Noguchi M; Shimosato Y; Sekiya T Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414 [TBL] [Abstract][Full Text] [Related]
8. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785 [TBL] [Abstract][Full Text] [Related]
9. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH. Wang ZR; Liu W; Smith ST; Parrish RS; Young SR Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442 [TBL] [Abstract][Full Text] [Related]
10. c-erbB-2 amplification in node-negative human breast cancer. Ro JS; el-Naggar A; Ro JY; Blick M; Frye D; Fraschini G; Fritsche H; Hortobagyi G Cancer Res; 1989 Dec; 49(24 Pt 1):6941-4. PubMed ID: 2573424 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033 [TBL] [Abstract][Full Text] [Related]
12. Amplification of the N-myc oncogene in an adenocarcinoma of the lung. Saksela K; Bergh J; Nilsson K J Cell Biochem; 1986; 31(4):297-304. PubMed ID: 3020069 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry. Stål O; Sullivan S; Sun XF; Wingren S; Nordenskjöld B Cytometry; 1994 Jun; 16(2):160-8. PubMed ID: 7924685 [TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas. Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035 [TBL] [Abstract][Full Text] [Related]
15. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization. Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259 [TBL] [Abstract][Full Text] [Related]
16. [Protooncogene c-myc amplification and cell cycle analysis in human malignant tumors]. Kita M; Okawa T; Hasegawa N; Maruyama I; Karasawa K; Kaneyasu Y; Tanaka M Gan To Kagaku Ryoho; 1993 Apr; 20(6):834-8. PubMed ID: 8489294 [TBL] [Abstract][Full Text] [Related]
17. [Preliminary studies on c-erbB-2 protooncogene in breast cancer]. He LW Zhonghua Zhong Liu Za Zhi; 1992 May; 14(3):171-4. PubMed ID: 1356719 [TBL] [Abstract][Full Text] [Related]
18. c-erbB-2 expression in primary gastric carcinomas and their metastases. David L; Seruca R; Nesland JM; Soares P; Sansonetty F; Holm R; Børresen AL; Sobrinho-Simões M Mod Pathol; 1992 Jul; 5(4):384-90. PubMed ID: 1353880 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes. Yokota J; Wada M; Yoshida T; Noguchi M; Terasaki T; Shimosato Y; Sugimura T; Terada M Oncogene; 1988 Jun; 2(6):607-11. PubMed ID: 2838790 [TBL] [Abstract][Full Text] [Related]
20. [Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up]. Nagai S; Chiba W; Ikeda S; Matsumoto H; Fujimoto T; Ishida H; Wazawa H; Hanawa T; Yamashita N; Yasuda Y; Matsubara Y; Hatakenaka R; Funatsu T Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():130-4. PubMed ID: 8678555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]